Biogen Idec (BIIB) Will Continue Being Active in M&A, Licensing - CEO Scangos
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) CEO George Scangos spoke with Bloomberg on Tuesday. The interview comes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
